1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics.
D000284:Administration, Oral; D000700:Analgesics / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001549:Benzamides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D003514:Cyclohexylamines / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D003864:Depression, Chemical; D004597:Electroshock; D007279:Injections, Subcutaneous; D051379:Mice; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D011809:Quinones / Q000037:antagonists & inhibitors; D011930:Reaction Time; D012640:Seizures / Q000517:prevention & control; D013329:Structure-Activity Relationship
D000700:Analgesics; D001549:Benzamides; D003514:Cyclohexylamines; D011809:Quinones; C006215:AH 7921; D010433:Pentylenetetrazole